Transfusion medicine as of 2014

Transfusion of blood components is one of the most common medical treatments, and in spite of the time that has evolved since we started to transfuse blood routinely in the 1930s, there are issues associated with its use that we are still trying to improve. Issues such as when to transfuse and adver...

Full description

Bibliographic Details
Main Authors: Lozano, Miguel, Cid, Joan
Format: Online
Language:English
Published: Faculty of 1000 Ltd 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229729/
id pubmed-4229729
recordtype oai_dc
spelling pubmed-42297292015-01-09 Transfusion medicine as of 2014 Lozano, Miguel Cid, Joan Review Article Transfusion of blood components is one of the most common medical treatments, and in spite of the time that has evolved since we started to transfuse blood routinely in the 1930s, there are issues associated with its use that we are still trying to improve. Issues such as when to transfuse and adverse effects associated with the transfusion are fields where new evidence is being generated that ideally should help us to indicate when and what to transfuse to the patients. The recognition that the evidence generated in randomized control trials was not widely applied to guide the indication of the transfusion of blood components has provoked the development of initiatives that try to reduce its unnecessary usage. Those initiatives, grouped under the name of patient blood management, have represented a significant paradigm change, and a growing number of activities in this field are performed in health-care facilities around the world. This article tries to summarize the latest publications in those fields. Faculty of 1000 Ltd 2014-11-04 /pmc/articles/PMC4229729/ /pubmed/25580259 http://dx.doi.org/10.12703/P6-105 Text en © 2014 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Lozano, Miguel
Cid, Joan
spellingShingle Lozano, Miguel
Cid, Joan
Transfusion medicine as of 2014
author_facet Lozano, Miguel
Cid, Joan
author_sort Lozano, Miguel
title Transfusion medicine as of 2014
title_short Transfusion medicine as of 2014
title_full Transfusion medicine as of 2014
title_fullStr Transfusion medicine as of 2014
title_full_unstemmed Transfusion medicine as of 2014
title_sort transfusion medicine as of 2014
description Transfusion of blood components is one of the most common medical treatments, and in spite of the time that has evolved since we started to transfuse blood routinely in the 1930s, there are issues associated with its use that we are still trying to improve. Issues such as when to transfuse and adverse effects associated with the transfusion are fields where new evidence is being generated that ideally should help us to indicate when and what to transfuse to the patients. The recognition that the evidence generated in randomized control trials was not widely applied to guide the indication of the transfusion of blood components has provoked the development of initiatives that try to reduce its unnecessary usage. Those initiatives, grouped under the name of patient blood management, have represented a significant paradigm change, and a growing number of activities in this field are performed in health-care facilities around the world. This article tries to summarize the latest publications in those fields.
publisher Faculty of 1000 Ltd
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229729/
_version_ 1613155773773250560